- Home
- CNTA vs CSQ Comparison
CNTA vs CSQ Comparison
Compare CNTA & CSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$27.73
Company Overview
Basic Information| Metric | CNTA | CSQ |
|---|---|---|
| Founded | 2020 | 2003 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTA | CSQ |
|---|---|---|
| Price | $27.73 | $18.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $40.89 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 241.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.60 | $13.11 |
| 52 Week High | $30.58 | $19.83 |
Technical Indicators
Market Signals| Indicator | CNTA | CSQ |
|---|---|---|
| Relative Strength Index (RSI) | 62.51 | 31.86 |
| Support Level | $21.93 | $17.29 |
| Resistance Level | $30.29 | $19.48 |
| Average True Range (ATR) | 1.18 | 0.30 |
| MACD | 0.14 | -0.08 |
| Stochastic Oscillator | 72.50 | 12.24 |
Price Performance
Historical Comparison CNTA
CSQ
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About CSQ Calamos Strategic Total Return
Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.